Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Comment by CerealKilleron Jan 22, 2021 3:21am
253 Views
Post# 32357039

RE:Sales and Earnings Power will push us to NEW HIGHS

RE:Sales and Earnings Power will push us to NEW HIGHS
Hiddensecrets wrote: I have read a few comments from posters.   When I post actual facts from reputable sources on the seriousness of covid19 and all the deaths, people say I am trying to scare others.   When I post actual facts on the possibility of lucrative sales being generated by a Hollywood type personality people saying that I am pumping. 

For fair disclosure to everyone, I bought at 16 cents (loaded up, way before anyone ever spoke of this company) and I will not sell unless if my return goes in the 1000%.    I do not trade around the stock, I do not put stop losses and I do not pump stocks nor post lies.

I do my due diligence and based on that I will decided to buy.   My selling point is when we reach fair market value.

Now what is this fair market value?

It is not 64 cents, I can tell you that. 

I will be conservative and say that they end 2021 with 300 cubes and, not 1,000 or 2,000 like they are projected.  I also assume that each cube will do 50 tests each on average.   And I also assume margins of say 35% on profits and not 55% and, say averga test is $ 75.

So per my calculation this is what sales will be on a 1 year basis, on very conservative side:

Sales:              300 cubes *50 tests each * $ 75 * 365 days =   $ 410,625,000

Profit margins:                        35% * $ 410,625,000              =     143,718,500

The testing will be around for several years as even with vaccines, employers will continue testing as companies cannot afford one lockdown after another.   I am assuming 3 years.

Total profits over 3 years:                143,718,500  * 3            =      431,156,500

Shares o/s                                                                                      170,000,000

Cash book value on cubes alone:                                                      $  2.53

No one trades at cash value.   They trade at 3 to 4 times cash value so $ 7.60 to $ 10.14 per share.

Now I have not included Sanity operations, sales that are made to Kinross types of companies, no sales made to sports teams, real-estate agent sales, no wellness sales, no vaccine sales, etc....

So based on 300 cubes with minimal successful operations, fair valu eis $ 7.60 to $ 10.14.

If MEDV surprises with 2,000 cubes and, we include all of the other revenue generators, then you are speaking of a $ 50 stock.

But people like usual do not do any homeword or due dilgence.  They live in fear.   If you do you homework you will realize that our CEO is aiming for a $ 2 billion per year operation, just lilke he had at Teva. 

MPO





Honestly, none of the posts here on Stockhouse matter at all regarding the share price, although you do make it difficult for investors to find real information. It's no coincidence that the share price started moving when Medivolve started gaining traction on Reddit though.That's the place where attention is gained. Stockhouse is a dinosaur and in Stockhouse's golden era the retail investor didn't matter much. That's not so in the days of Robinhood, r/wallstreetbets, etc.

Sarb99 should spend much more time over on Reddit promoting this stock rather than here and on ceo/ca. Hiddensecrets, please never post on Reddit (the subreddit mods would ban you anyway though, thank goodness).
<< Previous
Bullboard Posts
Next >>